China Drug Injection Industry Production & Marketing Demand and Investment Forecast Report, 2013-2017

Last Update:2014-05-01
Form of services:Book + (pdf or doc file) + CD
Send method:EMS 2-3 days for delivery
English Service:+86 0755 33220413
Chinese Service:+86 800-8306390 800-8306395
E-mail:service.en@qianzhan.com
Report price:$7900 Print: $7800 CD: $7800
This table of content is original, without written permission of Qianzhan, any unit or individual shall not use, copy, or transfer the reports.
Preface
Table of Content
China has stepped into an aging society since 2000. By 2010, population to China is 1.339 billion of which the 60-year-old or above accounts for 13.26%. And it will be a fast growing period for China aging population from 2011 to 2040. It is predicted that the 60-year-old or above will reach 0.2 billion in 2014 while it will be 0.3 billion in 2026 and China will become a super aging country.
The accelerating aging will benefit the medical industry from a long-term view. And considering from the prevalence rate of chronic disease for the aging, it is as high as 64.5%. Moreover, the course of treatment is long in many cases and with poor prognosis and large cost. View from the medicine consumption ratio for the aging, it is over 50%. Therefore, the accelerating progress of the aging will surely promote the demand of medicine. What’s more, due to the advantages such as rapid and reliable effect, the injection products will be more popular for patients.
And as the Chinese medicine has a special effect on chronic geriatric, the proportion of Chinese medicine consumption to total consumption for the aging is over 60%. There are two major markets for Chinese medicine injection products: the cardiovascular drugs market and the cancer drug market which will mostly benefit from the market expansion due to the aging trend, income and expense growth of medicine consumption.
In the meantime, health of the young and the middle age is threatened by fierce competition and high work pressure. The sub-health is universal which brings along the medical demand. Moreover, the “rich man’s disease” (including diabetes, breast cancer and angiocardiopathy) is along with the fast growth of economy. The prevalence rate is leaping. The medical demand for the treatment of such diseases, and the increasing income make the China injection market maintains a rapid growth. Especially since 2008, the average annual growth rate is over 20%. Forward predicts that the market scale of China injection industry will break through 220 billion Yuan in 2011.
Here, we’d like to express our sincere gratitude to National Statistics Bureau of China, International Information Institute, National Institute of the Ministry of Commerce, National Tsing Hua University Library, Institute of Market Economy of the State Council Development Research Center, and Beijing Qinghua Forward Market Research Center, etc. Thank you so much!
Notice: all the market data, especially the corporation list data in this report is only for business reference. Please don’t take the data for enterprise publicity. Thank you! Or Forward shall not take any responsibility for any consequences!
Qianzhan Business Information Co., Ltd. Industry Research Center
Research Team of Drug Injection Industry
China Drug Injection Industry Report" related reports »
- China Chemical Pharmaceutical Industry Market Monitoring Monthly Report, January
- Chinese Patent Medicine Industry Market Monitoring Monthly Report
- China Medicine Industry Market Monitoring Monthly Report
- China Chemical Pharmaceutical Industry Market Monitoring Monthly Report
- China Gallbladder and Liver Disease Medical Industry Market Forecast and Investment Strategy Report, 2013-2017
- China Diagnostic Reagent Industry Production & Marketing and Investment Forecast Report, 2013-2017
- China Cardiovascular System Drugs Industry Market Demand Forecast and Investment Strategy Planning, 2013-2017
- China Respiration System Chemical Medicine Industry Competitive Landscape and Leading Enterprise Research Report, 2013-2017
- Chinese Medicine Injection Industry Prospects and Investment Forecast Report, 2013-2017
- China Disinfection & Sterilization equipment Industry Production & Marketing Demand and Investment
- China Third-party Medical Diagnosis Industry Market Forecast and Investment Strategy Planning Report, 2013-2017
- China Pharmaceutical Excipients Industry Indepth Research and Investment Strategic Planning Report, 2013-2017
- China Drug Procurement and Agency Industry Report 2014-2018, Market Prospect and Investment Strategic Planning
- China Diabetes Medication Industry Analysis Report 2014-2018, Investment Forecast and Demand of Production and Sale
- China Radiation Protection Medicine Industry Report, Market Research and Development Prospect
- China Veterinary Medicine Industry Production & Marketing and Investment Forecast Report
- China Disease Prevention and Control Industry Report 2014-2018, Market Prospect and Investment Strategic Planning
- China In-Vitro Diagnosis Industry Indepth Research and Investment Strategy Planning Report, 2013-2017
- China Diagnostic Reagent Industry Production Marketing and Investment Forecast Report, 2013-2017
- China Dental Medical Industry Market Forward and Investment Strategy Report, 2013-2017
- China Penicillin Industry Research Report (2014-2018), Market Demand & Investment Forecast
- China Anesthetic Agent Industry Indepth Research and Investment Strategy Planning Report, 2013-2017
- China Marine Biological Medicine Industry Indepth Research and Investment Strategy Planning Report, 2013-2017
- China Antihypertensive Drug Industry Report (2014-2018), In-depth Research and Investment Strategic Planning
- China Herbal Pieces Processing Industry Production & Marketing Demand and Investment Forecast Report, 2013-2017
1. English Service: +86 0755 33220413
2. Chinese Service: +86 8008306390 8008306395
3. Mail Order: service.en@qianzhan.com
4. Online Order: Click "Order Now" button on this page
5. Purchase On-site: 19F Block A, First World Plaza, Hongli West Rd, Futian District, Shenzhen China
- 1. Please be aware of " Qianzhan " trademark, qianzhan has never used any third to sell reports, please make a phone call and purchase it directly.
- 2. You are warmly welcome to visit Qianzhan, and close transaction after confirmation.
- ·Energy and Environment»
- New Energy Natural Gas Energy Conservation Water Resources Coal Electricity Others
- ·Recreation and Sports»
- Education Advertisement Film and Television Publication Packing and Printing Sports Resort Hotel Catering Internet Animation Others Media
- ·Transport Logistics and Supporting»
- Water Transport Airport Road Transport Logistic Distribution Vehicle and Fittings Post-Market Others
- ·Medical and Health»
- Medical Device Biomedicine Medical Institution Healthcare and Nursing Medicine and Pharmacy Others
- ·Retail or FMCG»
- Retail Commercial Trade Food Beverage Dairy Product Seasoning Wine and Tobacco Cosmetics Cleaning Product Daily Necessities Others
- ·Real Estate and Construction»
- Real Estate Real Estate Intermediary Public Safety Construction Engineering Survey and Design Building Materials Housing Accomodation Others
- ·Mechanical Manufacturing»
- Precision Instrument Transport Instrument Electricity Supporting Equipment Special Equipment General Equipment Others
- ·New Chemical Material»
- Ink and Pigment Coating Chemical Fibres Synthetic Fibres Chemicals Industrial Chemicals Rubber Plastics Basic Chemicals Others
- ·Light Textile and Clothing»
- Luxury Jewelry Leather Raw Materials Shoes and Hats Clothing Textile Others
1. The copyright of this report is reserved by Qianzhan Business Information Co., Ltd. (Industry Research Institute of Qianzhan), the shipment and post-sale service is handled by the issue department of Qianzhan Business Information Co., Ltd. (Industry Research Institute of Qianzhan). The only copyright of all research report products of our company is reserved; we did not authorize any third party sales agent, if you are to purchase our report, please contact our customer service directly.
2. A limited of customers are offered with our reports with compensation; those reports are only for internal usage and are only for researching and analyzing purposes. We will not be responsible for any misunderstanding or legal issues caused by external usage or references with the report.
More>>